BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25120704)

  • 21. [Trichostatin A Induced Bcl-2 Protein Level Decrease Mediated A549/CDDP Cells Apoptosis by Mitochondria Pathway.].
    Wu J; Hu C
    Zhongguo Fei Ai Za Zhi; 2009 Nov; 12(11):1143-9. PubMed ID: 20723360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer.
    Xie Y; Peng Z; Shi M; Ji M; Guo H; Shi H
    Mol Med Rep; 2014 Nov; 10(5):2346-50. PubMed ID: 25118792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.
    Yang Y; Zhang P; Zhao Y; Yang J; Jiang G; Fan J
    Cancer Biol Ther; 2016 May; 17(5):515-25. PubMed ID: 26492332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.
    Shen H; Wang L; Ge X; Jiang CF; Shi ZM; Li DM; Liu WT; Yu X; Shu YQ
    Oncotarget; 2016 Apr; 7(15):20728-42. PubMed ID: 26989074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different mechanisms of cisplatin resistance development in human lung cancer cells.
    Okamoto K; Saito Y; Narumi K; Furugen A; Iseki K; Kobayashi M
    Biochem Biophys Res Commun; 2020 Oct; 530(4):745-750. PubMed ID: 32782152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism.
    Hou XB; Li TH; Ren ZP; Liu Y
    Biomed Pharmacother; 2016 Dec; 84():1575-1584. PubMed ID: 27825799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin.
    Hu W; Jin P; Liu W
    Cell Physiol Biochem; 2016; 38(3):1199-208. PubMed ID: 26982182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
    Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells.
    Taylor CA; Zheng Q; Liu Z; Thompson JE
    Mol Cancer; 2013 May; 12():35. PubMed ID: 23638878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.
    Horibe S; Matsuda A; Tanahashi T; Inoue J; Kawauchi S; Mizuno S; Ueno M; Takahashi K; Maeda Y; Maegouchi T; Murakami Y; Yumoto R; Nagai J; Takano M
    Life Sci; 2015 Mar; 124():31-40. PubMed ID: 25625243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
    Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
    Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formaldehyde induces apoptosis through decreased Prx 2 via p38 MAPK in lung epithelial cells.
    Lim SK; Kim JC; Moon CJ; Kim GY; Han HJ; Park SH
    Toxicology; 2010 May; 271(3):100-6. PubMed ID: 20347000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT.
    Yu M; Zhang C; Li L; Dong S; Zhang N; Tong X
    Oncol Rep; 2014 Jun; 31(6):2751-8. PubMed ID: 24789679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
    Tung CL; Jian YJ; Chen JC; Wang TJ; Chen WC; Zheng HY; Chang PY; Liao KS; Lin YW
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):657-66. PubMed ID: 27026405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p38 MAPK signaling mediates mitochondrial apoptosis in cancer cells induced by oleanolic acid.
    Liu J; Wu N; Ma LN; Zhong JT; Liu G; Zheng LH; Lin XK
    Asian Pac J Cancer Prev; 2014; 15(11):4519-25. PubMed ID: 24969879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.
    Xiong Y; Zhao Y; Miao L; Lin CM; Huang L
    J Control Release; 2016 Dec; 244(Pt A):63-73. PubMed ID: 27840166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
    Matsunaga T; Yamaji Y; Tomokuni T; Morita H; Morikawa Y; Suzuki A; Yonezawa A; Endo S; Ikari A; Iguchi K; El-Kabbani O; Tajima K; Hara A
    Free Radic Res; 2014 Nov; 48(11):1371-85. PubMed ID: 25156503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
    Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.